Remarkably, we could confirm our finding from the group of newly diagnosed patients also for all CRC patients analyzed: patients with low MACC1 levels (<cut-off) showed a significantly longer survival time than patients with high MACC1 levels (>cut-off) (P<.0001; Fig. 3B). Here, MACC1 is linked to colorectal carcinoma.